Search for: "PREFERRED PHARMACEUTICALS, INC"
Results 121 - 140
of 431
Sort by Relevance
|
Sort by Date
10 Sep 2018, 7:49 pm
Stamer’s clients include employers and other workforce management organizations; employer, union, association, government and other insured and self-insured health and other employee benefit plan sponsors, benefit plans, fiduciaries, administrators, and other plan vendors; managed care organizations, insurers, self-insured health plans and other payers and their management; public and private, domestic and international hospitals, health care systems, clinics, skilled nursing, long… [read post]
13 Jul 2018, 10:37 pm
Ron Kind (D-WI), which seeks to fight obesity and promote wellness by allowing taxpayers to use tax-preferred accounts to pay costs of gym membership or exercise classes, children’s school sports programs and certain other wellness programs and activities. [read post]
5 Jul 2018, 8:36 am
Green Shades Software, Inc., whereby the U.S. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
5 Jul 2018, 7:20 am
Teva Pharmaceuticals, USA, Inc., 429 F.3d 1364 (Fed. [read post]
19 Apr 2018, 6:30 am
Author Rebecca Shafer, JD, President of Amaxx Risk Solutions, Inc. is a national expert in the field of workers compensation. [read post]
6 Apr 2018, 10:37 am
Harris Funeral Homes, Inc.). [read post]
7 Jan 2018, 8:15 pm
Amazon.com, Inc. [read post]
3 Jan 2018, 8:00 am
While Abbott may have preferred a trial in St. [read post]
26 Dec 2017, 12:55 pm
Exeltis USA Inc. v. [read post]
15 Oct 2017, 3:00 am
Gilead Pharmaceuticals, Inc., C.A. [read post]
15 Oct 2017, 3:00 am
Gilead Pharmaceuticals, Inc., C.A. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
20 Sep 2017, 7:11 am
Solvay Pharmaceuticals, Inc., No. 16-20259 (5th Cir. [read post]
18 Sep 2017, 2:42 am
QXQ Inc. [read post]
24 Aug 2017, 5:32 pm
Shire US Holdings, Inc., C.A. [read post]
21 Jul 2017, 8:33 am
Here, there was no evidence that anyone "foresaw, or expected, or would have intended, the reaction between bortezomib and mannitol, or that the resulting ester would have the long-sought properties and advantages" and hence the invention was non-obvious.link: http://www.patentdocs.org/2017/07/millennium-pharmaceuticals-inc-v-sandoz-inc-fed-cir-2017.htmlIPBiz notes that obviousness relates to that which is known or reasonably foreseeable. [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
18 Apr 2017, 6:52 am
See Ariad Pharms., Inc. v. [read post]
